Skip to main content
ChenDermatologist
ChenDermatologist
Dr. Chen Yi-Jia · Dermatology Notes
English version. Prefer Traditional Chinese? Switch to Chinese
Patient guide · Myth busting Updated · 2026-05-04

6 Shingles (Herpes Zoster) Myths
Is wrap-around fatal? Is the vaccine worth it? How long does the neuralgia last?

Herpes zoster (commonly called Shingles) is reactivation of dormant varicella zoster virus (VZV) when age or immunosuppression weakens immunity. In Taiwan, 1 in 3 people over 50 will experience an episode. The folk belief that "it kills if it circles your body" is wrong, but Antiviral not started within 72 hours genuinely increases the risk of post-herpetic neuralgia (PHN). This article covers 6 of the most common misconceptions and whether to get the Shingrix vaccine.

Emergency reminder:Lumps located on the Forehead, periorbital area, nose tip (Hutchinson sign) may be "herpes zoster ophthalmicus" — immediate ophthalmology referral required. Ear involvement with asymmetric facial weakness may be Ramsay Hunt syndrome — immediate medical attention required.
Shingles follows a unilateral dermatomal distribution
Shingles appears unilaterallyDistributed along thoracic dermatomes 6-8Does not cross the midlineV1 ophthalmic branch of trigeminal nerveTip-of-nose lesion → eye involvement possible⏱ 72-hour golden windowAntiviral within 72 hr of rash onsetSubstantially reduces PHN riskShingrix vaccine≥50 yrs / ≥18 yrs immunocompromised2-dose protection > 90%Post-herpetic neuralgia (PHN)10-30% of patients have persistent painMonths to years

Myth 1: Shingles wrapping around the body is fatal

"Shingles wrapping all the way around your body kills you."
This is medically incorrect. Shingles (herpes zoster) follows nerve dermatomes — usually unilateral. Bilateral or "encircling" presentations are rare but not lethal; they may indicate immunocompromise warranting evaluation.

The myth comes from cases that progressed to disseminated zoster in immunocompromised patients (HIV, chemotherapy, transplant). The "encircling" image is a folkloric explanation, not pathophysiology.

Myth 2: Shingles is "caused by stress"

"I got shingles because of work stress."
Stress may be a trigger, but the cause is VZV reactivation. Anyone who had chickenpox in childhood carries dormant VZV that can reactivate later in life.

True risk factors: age > 50, immunosuppression (HIV, cancer, biologic / steroid therapy, transplant), chronic disease (DM, CKD, autoimmune). Stress alone in healthy young people rarely triggers it.

Myth 3: Young people don't get shingles

"I'm only 25 — shingles is for old people."
Although age > 50 carries higher risk, young adults can absolutely develop shingles. Recent epidemiology shows rising incidence in 20-40 year olds.

Myth 4: Topical creams / aloe / antiseptic are enough

"I'll just use aloe vera or antiseptic — no need for pills."
Shingles needs oral antiviral within 72 hours of rash onset to: (1) shorten course, (2) prevent dissemination, and most importantly (3) reduce postherpetic neuralgia (PHN) risk.

Standard regimens (start within 72h of rash):

  • Valacyclovir 1000 mg PO TID × 7 days (preferred — better bioavailability)
  • Famciclovir 500 mg PO TID × 7 days
  • Acyclovir 800 mg PO 5×/day × 7-10 days

Myth 5: Shingles isn't contagious

"Shingles can't spread to others."
Shingles vesicle fluid contains infectious VZV. People who never had chickenpox or vaccination can catch chickenpox (not shingles) on contact.

High-risk contacts: pregnant women without immunity, immunocompromised, infants. Cover lesions until fully crusted (~7 days). Once crusted, no longer contagious.

Myth 6: Shingrix vaccine is too expensive to be worth it

"Shingrix is over NT$ 12,000 — not worth it."
Shingrix has ~97% efficacy in preventing shingles in adults 50+ (ZOE-50 trial; Lal et al. NEJM 2015). PHN can last months to years with severe pain — far costlier than vaccination.

Recommendations: ≥ 50 years old (or ≥ 18 with immunocompromise), 2 doses 2-6 months apart. Self-paid in Taiwan ~NT$ 7,000-9,000/dose. Clear benefit even in those who already had shingles (recurrence rate up to 6%).

Treatment Strategy

PhaseTreatment
Acute (rash < 72h)Oral antiviral (Valacyclovir 1000 mg TID × 7d) + analgesia + topical care
Pain managementAcetaminophen → NSAID → low-dose opioid; gabapentin / pregabalin if neuropathic component
Severe / facial / immunocompromisedIV acyclovir + ophthalmology if eye involvement (V1)
PHN preventionAntiviral within 72h is the best preventive measure
PHN treatmentGabapentin / pregabalin / TCAs / topical lidocaine / capsaicin patch
VaccinationShingrix 2-dose series for ≥ 50yo (or ≥ 18 immunocompromised)

Summary

Shingles is a treatable disease where early antiviral therapy (within 72h) dramatically affects outcome. The biggest threat is PHN, which can last years. Adults 50+ should consider Shingrix vaccination. Don't underestimate "burning rash" — see a dermatologist within 72 hours.